Perrigo New Product Program, Quality Control Back On Track In FY 2002
This article was originally published in The Tan Sheet
Executive Summary
Corrective actions taken in response to an unfavorable FDA inspection of Perrigo's Allegan, Mich. facility will preclude the planned November launch of minoxidil 5% and stall the company's pipeline, Perrigo told analysts in an Oct. 25 conference call.
You may also be interested in...
Perrigo Vitamin Sales Jump 20%, OTCs Up 13% In Fiscal First Quarter
Perrigo's vitamin and supplement sales posted double-digit gains in the fiscal first quarter ended Sept. 29, fueled primarily by letter vitamins and glucosamine/ chondroitin supplements, the firm announced Oct. 23.
Perrigo Vitamin Sales Jump 20%, OTCs Up 13% In Fiscal First Quarter
Perrigo's vitamin and supplement sales posted double-digit gains in the fiscal first quarter ended Sept. 29, fueled primarily by letter vitamins and glucosamine/ chondroitin supplements, the firm announced Oct. 23.
Perrigo Vitamin Sales Jump 20%, OTCs Up 13% In Fiscal First Quarter
Perrigo's vitamin and supplement sales posted double-digit gains in the fiscal first quarter ended Sept. 29, fueled primarily by letter vitamins and glucosamine/ chondroitin supplements, the firm announced Oct. 23.